Kaitlyn D’Onofrio

DocwireNews

The ASCO20 Virtual Education Program took place Aug. 8&ndash;10. Here are some of the trending titles that have people talking.<a href="https://dailynews.ascopubs.org/do/10.1200/ADN.20.200280/full/">Targeting Early-Onset Colorectal Cancer</a>Although colorectal cancer mortality (CRC) in the United States as a whole is on the decline, increases have been observed in diagnoses among patients aged younger than 50 years&mdash;defined as early-onset CRC. An estimated 3,640 patients will die from early-onset CRC this year alone. An Education Session titled, &ldquo;Colorectal Cancer in Young Adults: A Distinct Entity&rdquo; discussed early-onset CRC, including screening and diagnosis rates as well as strategies to reduce early-onset CRC. (<a href="https://dailynews.ascopubs.org/do/10.1200/ADN.20.200280/full/">Read more here: Education and Communication Key in Reversing Trends in Early-Onset Colorectal Cancer</a>)<a href="https://dailynews.ascopubs.org/do/10.1200/ADN.20.200295/full/">RAS-Mutant Cancer Treatment Updates</a>About 19% of cancer patients have a RAS mutation, point to a a significant need for treatments for these cancers. An Education Session, &ldquo;ASCO/American Association for Cancer Research (AACR) Joint Session: Targeting RAS&ndash;Driven Cancers,&rdquo; discussed the latest news in the treatment landscape for RAS-mutant cancers. (<a href="https://dailynews.ascopubs.org/do/10.1200/ADN.20.200295/full/">Read more here: New Treatment Strategies Target RAS&ndash;Driven Cancers</a>)<a href="https://www.vjoncology.com/video/g88fevjri90-targeted-therapy-in-nsclc-at-asco-2020/">Targeted NSCLC Therapy</a>In a video, Riyaz Shah, FRCP, PhD, Maidstone and Tunbridge Wells NHS Trust, Kent, UK, talks about the ADAURA study as well as other recent data regarding targeted therapies for non-small cell lung cancer (NSCLC). (<a href="https://www.vjoncology.com/video/g88fevjri90-targeted-therapy-in-nsclc-at-asco-2020/">Watch here: ASCO 2020 | Targeted therapy in NSCLC at ASCO 2020</a>)<a href="https://www.onclive.com/view/asco-2020-data-drive-new-discussions-in-nsclc">Updates on NSCLC</a>During an OncLive video program, Joshua M. Bauml, MD, assistant professor of medicine, Perelman School of Medicine, University of Pennsylvania, discussed NSCLC updates highlighted during the 2020 ASCO Virtual Scientific Program. Dr. Bauml and other experts talked about the ADAURA trial, looking ahead at NSCLC treatment, and more. (<a href="https://www.onclive.com/view/asco-2020-data-drive-new-discussions-in-nsclc">Read more here: ASCO 2020 Data Drive New Discussions in NSCLC</a>)<a href="https://www.docwirenews.com/latest-featured-news/bite-immuno-oncology-platform/">BiTE&reg; Technology: Changing the Cancer Treatment Landscape</a>Bispecific T-cell engager (BiTE&reg;) technology can be beneficial for cancer patients who may not see success with current treatments. This video, presented by Amgen, describes the BiTE&reg;&nbsp;immuno-oncology platform and how it can aid these patients. (<a href="https://www.docwirenews.com/latest-featured-news/bite-immuno-oncology-platform/">Watch here: BiTE&reg;&nbsp;Immuno-Oncology Platform: Designed to Engage the Natural Power of T-Cells</a>)Continue the conversation on social media using the <a href="https://mashupmd.com/nikhil-munshi-m-d-on-karmma-in-relapsed-refractory-mm-asco2020/">hashtag #ASCO20</a>

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Trending Titles from #ASCO20: NSCLC, Early-Onset CRC, and more

Conference Coverage

The ASCO20 Virtual Education Program took place Aug. 8–10. Here are some of the trending titles that have people talking.
 ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe